Navigation Links
Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
Date:1/24/2011

r>.17

(a)$   0.92$
.05

(a)Average shares used in calculation of earnings per share:Basic 9409401,0061,006Diluted (l)946946

(a)1,0111,012

(a)(a) - (l)   See explanatory notes on the following pages.   Amgen Inc.Condensed Consolidated Statements of Income andReconciliation of GAAP Earnings to "Adjusted" Earnings (In millions, except per share data)(Unaudited)Year endedYear endedDecember 31, 2010December 31, 2009GAAPAdjustments

"Adjusted"GAAPAdjustments

"Adjusted"Revenues:Product sales$ 14,660$
-$  14,660$ 14,351$
-$  14,351Other revenues393-393291-291Total revenues15,053-15,05314,642-14,642Operating expenses:Cost of sales (excludes amortization of certain acquired intangible assets presented below) 2,220(15)

(a)2,2052,091(12)

(a)2,078(1)

(f)Research and development2,894(51)

(a)2,7732,864(49)

(a)2,739(70)

(b)(70)

(b)(6)

(f)Selling, general and administrative3,983(58)

(a)3,9253,820(54)

(a)3,737(29)

(f)Amortization of certain acquired intangible assets294(294)

(c)-294(294)

(c)-Other 117(118)

(d)-67(33)

(e)-1

(e)(34)

(f)Total operating expenses9,508(605)8,9039,136(582)8,554Operating income5,5456056,1505,5065826,088 Interest expense, net604(266)

(g)338578(250)

(g)328 Interest and other income, net376-376276-276Income before income taxes5,3178716,1885,2048326,036Provision for income taxes690318

(h)1,164599293

(h)1,022151

(i)87

(i)5

(j)18

(j)25

(k)Net income $   4,627$ 397$
5,024$   4,605$ 409$
5,014Earnings per share:Basic $
4.82$
5.23$
4.53$
4.94Diluted (l)$
4.79$
5.21

(a)$
4.51$
4.91

(a)Average shares used in calculation of earning
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...
(Date:5/21/2013)... 21, 2013  Armada Health Care (Armada) is ... Armada corporate website ( www.armadahealthcare.com ).  This new ... and first-to-market services and its position as the ... specialty pharmacy industry. The updated website ... business model in delivering an extensive portfolio of ...
(Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...
... Md., Feb. 23, 2011 The Cystic Fibrosis Foundation and ... development that targets the defective protein that causes cystic fibrosis, ... The trial was designed to evaluate patients age ... a CF mutation called G551D. The study included 161 patients ...
Cached Medicine Technology:Healthpoint Launches New Corporate Identity 2Healthpoint Launches New Corporate Identity 3Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
(Date:5/21/2013)... (PRWEB) May 21, 2013 Diversity Focus, ... working environments for all residents in the Creative Corridor ... Community Survey at a news conference on Thursday, May ... benchmark study, conducted in 2008. , The ... to lead and support efforts that attract, nurture and ...
(Date:5/21/2013)... May 21, 2013 MedMar Healing Center ... to benefit Second Harvest Food Bank. Twenty-eight businesses, including MedMar ... in the food drive. The goal is to raise food ... economic problems facing their families in recent years. , ... and help those in need,” explains Douglas Chloupek of MedMar ...
(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...
(Date:5/21/2013)... Colo. (May 21, 2013) Research into genetic features ... University of Colorado School of Medicine may lead to ... a paper published online by JAMA . , ... predict survival in some cases of pulmonary fibrosis, a ... years. As a result of the study, researchers may ...
(Date:5/21/2013)... and technological research So Paulo Research Foundation, FAPESP, based ... estimated in US$ 680 million to support 17 Research, ... up to eleven years, subject to continuation reviews on ... the 17 RIDCs will come from FAPESP and the ... infrastructure). Host institutions will participate in a portion of ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2
... University School of Medicine in St. Louis, Missouri, have ... lead to treatments for deadliest poisons like Ricin, cholera ... the deadly strains of E. coli bacteria, these toxins ... the Golgi network and endoplasmic reticulum before interrupting protein ...
... from Eli Lilly and Company and the ... the genetic mutation that may alter tumour cell proliferation, ... ,The researchers say that they found a ... and ovarian cancers. ,The AKT pathway ...
... vineyards and launching an overseas marketing blitz under ... glut and countering New World producers. ,Farm ... wine budget of 1.3 billion euros (1.8 billion dollars) ... huge challenges facing the sector. ,"We are ...
... ended the six-year reign of a Japanese champion Wednesday, gobbling ... the annual Nathan's Famous Hot Dog Eating contest. ... streak to the cheers of a crowd of 50,000, according ... dropping out of the event after arthritis of the jaw ...
... protein that, in rats, rescues brain cells whose death ... the central nervous system. ,The new molecule, ... of cells that produce the key brain chemical dopamine ... ,Tested on lab rodents engineered to have Parkinson's, ...
... at the scene of a variety of tumors is implicated ... in a paper by researchers at The University of ... the Proceedings of the National Academy of Sciences. ... that its actually causing cancer. In this paper we show ...
Cached Medicine News:Health News:Genetic Mutation That Makes Common Cancers Resistant to Drugs Identified 2Health News:EU Aims to Shake Up Wine Industry With Root-and-branch Reform 2Health News:American Bests Japanese Hot Dog Eating Champion, Sets Record 2Health News:New Oncogene for Brain Cancer 2Health News:New Oncogene for Brain Cancer 3
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • Not available with casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Medicine Products: